| Product Code: ETC9678113 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Angiogenesis Inhibitors Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Angiogenesis Inhibitors Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Angiogenesis Inhibitors Market - Industry Life Cycle |
3.4 Thailand Angiogenesis Inhibitors Market - Porter's Five Forces |
3.5 Thailand Angiogenesis Inhibitors Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Thailand Angiogenesis Inhibitors Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Thailand Angiogenesis Inhibitors Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 Thailand Angiogenesis Inhibitors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Thailand Angiogenesis Inhibitors Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Thailand Angiogenesis Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Thailand Angiogenesis Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Thailand |
4.2.2 Growing adoption of targeted therapies for cancer treatment |
4.2.3 Rising healthcare expenditure and investment in oncology research |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approvals |
4.3.2 High cost associated with angiogenesis inhibitors |
4.3.3 Limited awareness among healthcare providers and patients about angiogenesis inhibitors |
5 Thailand Angiogenesis Inhibitors Market Trends |
6 Thailand Angiogenesis Inhibitors Market, By Types |
6.1 Thailand Angiogenesis Inhibitors Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Thailand Angiogenesis Inhibitors Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Thailand Angiogenesis Inhibitors Market Revenues & Volume, By VEGF Targeted Therapy, 2021- 2031F |
6.1.4 Thailand Angiogenesis Inhibitors Market Revenues & Volume, By FGF Targeted Therapies, 2021- 2031F |
6.1.5 Thailand Angiogenesis Inhibitors Market Revenues & Volume, By Oncogene Targeted Therapy, 2021- 2031F |
6.1.6 Thailand Angiogenesis Inhibitors Market Revenues & Volume, By Matrix Degrading and Remodeling Targeted Therapy, 2021- 2031F |
6.1.7 Thailand Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Thailand Angiogenesis Inhibitors Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Thailand Angiogenesis Inhibitors Market Revenues & Volume, By Glioblastoma, 2021- 2031F |
6.2.3 Thailand Angiogenesis Inhibitors Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.4 Thailand Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Thailand Angiogenesis Inhibitors Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 Thailand Angiogenesis Inhibitors Market Revenues & Volume, By Inlyta, 2021- 2031F |
6.3.3 Thailand Angiogenesis Inhibitors Market Revenues & Volume, By Avastin, 2021- 2031F |
6.3.4 Thailand Angiogenesis Inhibitors Market Revenues & Volume, By Revlimid, 2021- 2031F |
6.3.5 Thailand Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Thailand Angiogenesis Inhibitors Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Thailand Angiogenesis Inhibitors Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Thailand Angiogenesis Inhibitors Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 Thailand Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Thailand Angiogenesis Inhibitors Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Thailand Angiogenesis Inhibitors Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Thailand Angiogenesis Inhibitors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Thailand Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Thailand Angiogenesis Inhibitors Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Thailand Angiogenesis Inhibitors Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Thailand Angiogenesis Inhibitors Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Thailand Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
7 Thailand Angiogenesis Inhibitors Market Import-Export Trade Statistics |
7.1 Thailand Angiogenesis Inhibitors Market Export to Major Countries |
7.2 Thailand Angiogenesis Inhibitors Market Imports from Major Countries |
8 Thailand Angiogenesis Inhibitors Market Key Performance Indicators |
8.1 Number of clinical trials involving angiogenesis inhibitors in Thailand |
8.2 Adoption rate of angiogenesis inhibitors in cancer treatment protocols |
8.3 Number of research publications on the efficacy of angiogenesis inhibitors in cancer treatment |
8.4 Level of government funding allocated to oncology research and development in Thailand |
8.5 Number of partnerships and collaborations between pharmaceutical companies and research institutions in the field of angiogenesis inhibitors |
9 Thailand Angiogenesis Inhibitors Market - Opportunity Assessment |
9.1 Thailand Angiogenesis Inhibitors Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Thailand Angiogenesis Inhibitors Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Thailand Angiogenesis Inhibitors Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 Thailand Angiogenesis Inhibitors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Thailand Angiogenesis Inhibitors Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Thailand Angiogenesis Inhibitors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Thailand Angiogenesis Inhibitors Market - Competitive Landscape |
10.1 Thailand Angiogenesis Inhibitors Market Revenue Share, By Companies, 2024 |
10.2 Thailand Angiogenesis Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here